Endeavor BioMedicines

company

About

Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$101M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.

The company was founded in 2018 and is based in Solana Beach, California, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$101M
Endeavor BioMedicines has raised a total of $101M in funding over 2 rounds. Their latest funding was raised on Feb 7, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 7, 2022 Series B $101M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Endeavor BioMedicines is funded by 1 investors. Piper Heartland Healthcare Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Piper Heartland Healthcare Capital Series B